Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis

Background. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) has received increasing attention and application as an effective noninvasive mode of ventilation in the treatment of clinical anesthesia and critically ill patients. The conclusions reached in clinical studies of THR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed research international 2022-07, Vol.2022, p.1-9
Hauptverfasser: Li, Yongkai, Yang, Jianzhong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue
container_start_page 1
container_title BioMed research international
container_volume 2022
creator Li, Yongkai
Yang, Jianzhong
description Background. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) has received increasing attention and application as an effective noninvasive mode of ventilation in the treatment of clinical anesthesia and critically ill patients. The conclusions reached in clinical studies of THRIVE and facemask oxygenation are still controversial, and the main objective of this systematic review is to determine the advantages of THRIVE over facemask oxygenation in intensive care units, respiratory medicine, and perioperative preoxygenation. Methods. PubMed, Embase, Web of Science, and Cochrane Library have search restrictions. The search library was full of English language articles from the first publication to 15 July 2021. Eligible randomized controlled study designs were included. 245 records were screened, and 5 studies met the inclusion criteria, enrolling a total of 235 patients. Results. Studying the THRIVE group compared to the facemask group, three studies analyzing intubation time showed that there is no difference in the effect of THRIVE and facemasks (MD -1.22, 95% CI -7.23 to 4.78, and P=0.69>0.05). Three studies analyzing apnea showed that there was no difference between the two groups (SMD 1, 95% CI -0.76 to 2.76, and P=0.27>0.05). Three studies analyzing PaO2 after preoxygenation showed that THRIVE is more effective than facemasks (MD 72.58, 95% CI 31.25 to 113.90, Z=3.44, and P0.05). Two studies analyzing PCO2 after complete paralysis or intubation preoxygenation showed that there was no difference between the two groups (MD 2.76, 95% CI -1.74 to 7.26, and P=0.23>0.05). Conclusions. THRIVE does not have a greater advantage over a facemask in improving apnea time, oxygenation time, PCO2, and SpO2, but it has an advantage in improving arterial partial pressure of oxygen (PaO2) after preoxygenation, which can improve PaO2 well. This trial is registered with the protocol registration number CRD42021268143.
doi_str_mv 10.1155/2022/9858820
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9300319</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A711332092</galeid><sourcerecordid>A711332092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-afe7b9f49444bbfd4cbd44d5d4e2c203149a2e4357308ac6c879a89cf94586cf3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEolXpjR9giQsSpHVsJ7E5IK1WLa1UBCqFqzXxx65LYi920nb_Br-43g8VwQFfPNI888689hTF6wqfVFVdnxJMyKngNecEPysOCa1Y2VSsev4UU3pQHKd0i_PhVYNF87I4oDVvCW-rw-L3PAwriC4Fj4JFNxF88pCgRxfT4LSzzmh0DSuny0ufJmt7GF1mfxg_uhyHuEZnD2oJfmEQeI3OQZkB0s-EnEdfowkP64Xx26IPaIa-rdOY86NT6NrcOXO_LfpsRihnHvp1culV8cJCn8zx_j4qvp-f3cwvyqsvny7ns6tSUU7HEqxpO2GZYIx1ndVMdZoxXWtmiCI4uxdADKN1SzEH1SjeCuBCWcFq3ihLj4qPO93V1A1Gq-woQi9X0Q0Q1zKAk39nvFvKRbiTguIsL7LA271ADL8mk0Y5uKRM34M3YUqSNHk2gvOjZ_TNP-htmGI2vKVo3QhB2z_UAnojnbch91UbUTlrq_yVBAuSqfc7SsWQUjT2aeQKy81WyM1WyP1WZPzdDl86r-He_Z9-BOOntu0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693569937</pqid></control><display><type>article</type><title>Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis</title><source>PubMed Central Open Access</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Li, Yongkai ; Yang, Jianzhong</creator><contributor>Patini, Romeo ; Romeo Patini</contributor><creatorcontrib>Li, Yongkai ; Yang, Jianzhong ; Patini, Romeo ; Romeo Patini</creatorcontrib><description>Background. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) has received increasing attention and application as an effective noninvasive mode of ventilation in the treatment of clinical anesthesia and critically ill patients. The conclusions reached in clinical studies of THRIVE and facemask oxygenation are still controversial, and the main objective of this systematic review is to determine the advantages of THRIVE over facemask oxygenation in intensive care units, respiratory medicine, and perioperative preoxygenation. Methods. PubMed, Embase, Web of Science, and Cochrane Library have search restrictions. The search library was full of English language articles from the first publication to 15 July 2021. Eligible randomized controlled study designs were included. 245 records were screened, and 5 studies met the inclusion criteria, enrolling a total of 235 patients. Results. Studying the THRIVE group compared to the facemask group, three studies analyzing intubation time showed that there is no difference in the effect of THRIVE and facemasks (MD -1.22, 95% CI -7.23 to 4.78, and P=0.69&gt;0.05). Three studies analyzing apnea showed that there was no difference between the two groups (SMD 1, 95% CI -0.76 to 2.76, and P=0.27&gt;0.05). Three studies analyzing PaO2 after preoxygenation showed that THRIVE is more effective than facemasks (MD 72.58, 95% CI 31.25 to 113.90, Z=3.44, and P&lt;0.001). Two studies analyzing oxygen saturation SpO2 after successful intubation showed that there was no difference in the effectiveness (MD 0.09, 95% CI -1.03 to 1.22, and P=0.87&gt;0.05). Two studies analyzing PCO2 after complete paralysis or intubation preoxygenation showed that there was no difference between the two groups (MD 2.76, 95% CI -1.74 to 7.26, and P=0.23&gt;0.05). Conclusions. THRIVE does not have a greater advantage over a facemask in improving apnea time, oxygenation time, PCO2, and SpO2, but it has an advantage in improving arterial partial pressure of oxygen (PaO2) after preoxygenation, which can improve PaO2 well. This trial is registered with the protocol registration number CRD42021268143.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2022/9858820</identifier><identifier>PMID: 35872871</identifier><language>eng</language><publisher>New York: Hindawi</publisher><subject>Anesthesia ; Apnea ; Bias ; Biomedical research ; Blood pressure ; Body mass index ; Clinical trials ; Collaboration ; Continuous positive airway pressure ; Dosage and administration ; Evidence-based medicine ; Health aspects ; Hospitals ; Intensive care units ; Intubation ; Libraries ; Mechanical ventilation ; Meta-analysis ; Methods ; Oxygen ; Oxygen content ; Oxygenation ; Paralysis ; Partial pressure ; Patient outcomes ; Patients ; Respiratory agents ; Respiratory therapy ; Review ; Software ; Systematic review ; Ventilators</subject><ispartof>BioMed research international, 2022-07, Vol.2022, p.1-9</ispartof><rights>Copyright © 2022 Yongkai Li and Jianzhong Yang.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2022 Yongkai Li and Jianzhong Yang. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Yongkai Li and Jianzhong Yang. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-afe7b9f49444bbfd4cbd44d5d4e2c203149a2e4357308ac6c879a89cf94586cf3</citedby><cites>FETCH-LOGICAL-c383t-afe7b9f49444bbfd4cbd44d5d4e2c203149a2e4357308ac6c879a89cf94586cf3</cites><orcidid>0000-0002-7308-0123 ; 0000-0002-2881-7632</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300319/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300319/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><contributor>Patini, Romeo</contributor><contributor>Romeo Patini</contributor><creatorcontrib>Li, Yongkai</creatorcontrib><creatorcontrib>Yang, Jianzhong</creatorcontrib><title>Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis</title><title>BioMed research international</title><description>Background. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) has received increasing attention and application as an effective noninvasive mode of ventilation in the treatment of clinical anesthesia and critically ill patients. The conclusions reached in clinical studies of THRIVE and facemask oxygenation are still controversial, and the main objective of this systematic review is to determine the advantages of THRIVE over facemask oxygenation in intensive care units, respiratory medicine, and perioperative preoxygenation. Methods. PubMed, Embase, Web of Science, and Cochrane Library have search restrictions. The search library was full of English language articles from the first publication to 15 July 2021. Eligible randomized controlled study designs were included. 245 records were screened, and 5 studies met the inclusion criteria, enrolling a total of 235 patients. Results. Studying the THRIVE group compared to the facemask group, three studies analyzing intubation time showed that there is no difference in the effect of THRIVE and facemasks (MD -1.22, 95% CI -7.23 to 4.78, and P=0.69&gt;0.05). Three studies analyzing apnea showed that there was no difference between the two groups (SMD 1, 95% CI -0.76 to 2.76, and P=0.27&gt;0.05). Three studies analyzing PaO2 after preoxygenation showed that THRIVE is more effective than facemasks (MD 72.58, 95% CI 31.25 to 113.90, Z=3.44, and P&lt;0.001). Two studies analyzing oxygen saturation SpO2 after successful intubation showed that there was no difference in the effectiveness (MD 0.09, 95% CI -1.03 to 1.22, and P=0.87&gt;0.05). Two studies analyzing PCO2 after complete paralysis or intubation preoxygenation showed that there was no difference between the two groups (MD 2.76, 95% CI -1.74 to 7.26, and P=0.23&gt;0.05). Conclusions. THRIVE does not have a greater advantage over a facemask in improving apnea time, oxygenation time, PCO2, and SpO2, but it has an advantage in improving arterial partial pressure of oxygen (PaO2) after preoxygenation, which can improve PaO2 well. This trial is registered with the protocol registration number CRD42021268143.</description><subject>Anesthesia</subject><subject>Apnea</subject><subject>Bias</subject><subject>Biomedical research</subject><subject>Blood pressure</subject><subject>Body mass index</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Continuous positive airway pressure</subject><subject>Dosage and administration</subject><subject>Evidence-based medicine</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Intensive care units</subject><subject>Intubation</subject><subject>Libraries</subject><subject>Mechanical ventilation</subject><subject>Meta-analysis</subject><subject>Methods</subject><subject>Oxygen</subject><subject>Oxygen content</subject><subject>Oxygenation</subject><subject>Paralysis</subject><subject>Partial pressure</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Respiratory agents</subject><subject>Respiratory therapy</subject><subject>Review</subject><subject>Software</subject><subject>Systematic review</subject><subject>Ventilators</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk1v1DAQhiMEolXpjR9giQsSpHVsJ7E5IK1WLa1UBCqFqzXxx65LYi920nb_Br-43g8VwQFfPNI888689hTF6wqfVFVdnxJMyKngNecEPysOCa1Y2VSsev4UU3pQHKd0i_PhVYNF87I4oDVvCW-rw-L3PAwriC4Fj4JFNxF88pCgRxfT4LSzzmh0DSuny0ufJmt7GF1mfxg_uhyHuEZnD2oJfmEQeI3OQZkB0s-EnEdfowkP64Xx26IPaIa-rdOY86NT6NrcOXO_LfpsRihnHvp1culV8cJCn8zx_j4qvp-f3cwvyqsvny7ns6tSUU7HEqxpO2GZYIx1ndVMdZoxXWtmiCI4uxdADKN1SzEH1SjeCuBCWcFq3ihLj4qPO93V1A1Gq-woQi9X0Q0Q1zKAk39nvFvKRbiTguIsL7LA271ADL8mk0Y5uKRM34M3YUqSNHk2gvOjZ_TNP-htmGI2vKVo3QhB2z_UAnojnbch91UbUTlrq_yVBAuSqfc7SsWQUjT2aeQKy81WyM1WyP1WZPzdDl86r-He_Z9-BOOntu0</recordid><startdate>20220713</startdate><enddate>20220713</enddate><creator>Li, Yongkai</creator><creator>Yang, Jianzhong</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7308-0123</orcidid><orcidid>https://orcid.org/0000-0002-2881-7632</orcidid></search><sort><creationdate>20220713</creationdate><title>Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis</title><author>Li, Yongkai ; Yang, Jianzhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-afe7b9f49444bbfd4cbd44d5d4e2c203149a2e4357308ac6c879a89cf94586cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anesthesia</topic><topic>Apnea</topic><topic>Bias</topic><topic>Biomedical research</topic><topic>Blood pressure</topic><topic>Body mass index</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Continuous positive airway pressure</topic><topic>Dosage and administration</topic><topic>Evidence-based medicine</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Intensive care units</topic><topic>Intubation</topic><topic>Libraries</topic><topic>Mechanical ventilation</topic><topic>Meta-analysis</topic><topic>Methods</topic><topic>Oxygen</topic><topic>Oxygen content</topic><topic>Oxygenation</topic><topic>Paralysis</topic><topic>Partial pressure</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Respiratory agents</topic><topic>Respiratory therapy</topic><topic>Review</topic><topic>Software</topic><topic>Systematic review</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Yongkai</creatorcontrib><creatorcontrib>Yang, Jianzhong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yongkai</au><au>Yang, Jianzhong</au><au>Patini, Romeo</au><au>Romeo Patini</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis</atitle><jtitle>BioMed research international</jtitle><date>2022-07-13</date><risdate>2022</risdate><volume>2022</volume><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Background. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) has received increasing attention and application as an effective noninvasive mode of ventilation in the treatment of clinical anesthesia and critically ill patients. The conclusions reached in clinical studies of THRIVE and facemask oxygenation are still controversial, and the main objective of this systematic review is to determine the advantages of THRIVE over facemask oxygenation in intensive care units, respiratory medicine, and perioperative preoxygenation. Methods. PubMed, Embase, Web of Science, and Cochrane Library have search restrictions. The search library was full of English language articles from the first publication to 15 July 2021. Eligible randomized controlled study designs were included. 245 records were screened, and 5 studies met the inclusion criteria, enrolling a total of 235 patients. Results. Studying the THRIVE group compared to the facemask group, three studies analyzing intubation time showed that there is no difference in the effect of THRIVE and facemasks (MD -1.22, 95% CI -7.23 to 4.78, and P=0.69&gt;0.05). Three studies analyzing apnea showed that there was no difference between the two groups (SMD 1, 95% CI -0.76 to 2.76, and P=0.27&gt;0.05). Three studies analyzing PaO2 after preoxygenation showed that THRIVE is more effective than facemasks (MD 72.58, 95% CI 31.25 to 113.90, Z=3.44, and P&lt;0.001). Two studies analyzing oxygen saturation SpO2 after successful intubation showed that there was no difference in the effectiveness (MD 0.09, 95% CI -1.03 to 1.22, and P=0.87&gt;0.05). Two studies analyzing PCO2 after complete paralysis or intubation preoxygenation showed that there was no difference between the two groups (MD 2.76, 95% CI -1.74 to 7.26, and P=0.23&gt;0.05). Conclusions. THRIVE does not have a greater advantage over a facemask in improving apnea time, oxygenation time, PCO2, and SpO2, but it has an advantage in improving arterial partial pressure of oxygen (PaO2) after preoxygenation, which can improve PaO2 well. This trial is registered with the protocol registration number CRD42021268143.</abstract><cop>New York</cop><pub>Hindawi</pub><pmid>35872871</pmid><doi>10.1155/2022/9858820</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7308-0123</orcidid><orcidid>https://orcid.org/0000-0002-2881-7632</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2022-07, Vol.2022, p.1-9
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9300319
source PubMed Central Open Access; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection
subjects Anesthesia
Apnea
Bias
Biomedical research
Blood pressure
Body mass index
Clinical trials
Collaboration
Continuous positive airway pressure
Dosage and administration
Evidence-based medicine
Health aspects
Hospitals
Intensive care units
Intubation
Libraries
Mechanical ventilation
Meta-analysis
Methods
Oxygen
Oxygen content
Oxygenation
Paralysis
Partial pressure
Patient outcomes
Patients
Respiratory agents
Respiratory therapy
Review
Software
Systematic review
Ventilators
title Comparison of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange and Facemasks in Preoxygenation: A Systematic Review and Meta-Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A09%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Transnasal%20Humidified%20Rapid-Insufflation%20Ventilatory%20Exchange%20and%20Facemasks%20in%20Preoxygenation:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=BioMed%20research%20international&rft.au=Li,%20Yongkai&rft.date=2022-07-13&rft.volume=2022&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2022/9858820&rft_dat=%3Cgale_pubme%3EA711332092%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2693569937&rft_id=info:pmid/35872871&rft_galeid=A711332092&rfr_iscdi=true